Dianosic raises €4.7M to bring treatment for chronic rhinitis into clinical trial. ▶︎ Click here to discover the press release.
Pr. Christian Debry – Philippe Bastide (CEO) – Marc Augustin (Chairman)
Share this article
Major Funding Milestone: Dianosic raises 4.7M€ – February 2023
Discover our other articles
We are pleased to announce the closing of a €7 million financing round. This milestone marks a major step forward for Dianosic and further…
Dianosic launches a WiSEED backed convertible bonds transaction to accelerate innovation in the treatment of chronic allergic rhinitis. This initiative aims to support the…
Dec 15, 2025
Dianosic shortlisted for the “Trophées des Entreprises Alsace 2024” award
Awards
We are delighted to announce that Dianosic is one of the nominees for the 2024 edition of the “Trophées des entreprises d’Alsace”. This selection…
